Evidence map›Paper›PMID 39409582›Full record

ReviewPlants (Basel, Switzerland)2024

Cross-Kingdom RNA Transport Based on Extracellular Vesicles Provides Innovative Tools for Plant Protection.

Yujin Zhao, Yanguang Zhou, Jingyan Xu, Sen Fan, Na Zhu, Qingling Meng, Shijie Dai, Xiaofeng Yuan

Abstract readReview
In one paragraph

Review in Plants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. International journal of nanomedicine · 2026
    Article
  9. Review
  10. Current issues in molecular biology · 2025
    Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yujin ZhaoSchool of Life Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Yanguang ZhouSchool of Life Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Jingyan XuSchool of Life Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Sen FanSchool of Life Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Na ZhuSchool of Life Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Qingling MengSchool of Life Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Shijie DaiSchool of Life Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Xiaofeng YuanSchool of Life Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.

Funding

National Natural Science Foundation of China 82173920
6 · The paper itself

Abstract

RNA interference (RNAi) shows great potential in plant defense against pathogens through RNA-mediated sequence-specific gene silencing. Among RNAi-based plant protection strategies, spray-induced gene silencing (SIGS) is considered a more promising approach because it utilizes the transfer of exogenous RNA between plants and microbes to silence target pathogen genes. The application of nanovesicles significantly enhances RNA stability and delivery efficiency, thereby improving the effectiveness of SIGS and further enhancing plant resistance to diseases and pathogens. This review explores the role of RNAi in plant protection, focusing on the cross-kingdom transport of small RNAs (sRNAs) via extracellular vesicles. It also explores the potential of nanotechnology to further optimize RNA-based plant protection, offering innovative tools and methods in modern plant biotechnology.

Indexed as

extracellular vesiclespathogensplant protectionRNAisRNA

Identifiers

PMID39409582
PMCPMC11479161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.